This paper explores key people and organization considerations as life sciences companies expand their operations in emerging markets, and move from labor arbitrage to sourcing knowledge work in order to spur innovation and control overall R&D cost. It draws on case studies to present considerations along four dimensions: talent, rewards, organization and culture.